Skip to main content
Erschienen in: Digestive Diseases and Sciences 10/2015

01.10.2015 | Original Article

Screening for Zinc Deficiency in Patients with Cirrhosis: When Should We Start?

verfasst von: Shreya Sengupta, Kristen Wroblewski, Andrew Aronsohn, Nancy Reau, K. Gautham Reddy, Donald Jensen, Helen Te

Erschienen in: Digestive Diseases and Sciences | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Zinc deficiency has been observed in cirrhosis, but management guidelines do not address screening for zinc deficiency. We aim to determine the prevalence of zinc deficiency in different stages of cirrhosis and to correlate zinc levels with complications of cirrhosis and clinical outcomes. Patients who had a diagnosis of cirrhosis and had serum zinc levels drawn from 2007 to 2011 were identified. Demographics, laboratory data, presence of ascites, encephalopathy, and infection were obtained; Child–Pugh and MELD scores were calculated. Stata software was used for data analysis. A total of 163 patients were included in the study.

Results

The median serum zinc level was 0.47 mcg/ml (IQR 0.37–0.63); 83 % of patients were zinc deficient. Zinc deficiency was more prevalent in patients with Child–Pugh score B or C, and with MELD scores ≥15. Zinc levels were lower in alcoholic, hepatitis C, and cholestatic diseases than in other etiologies of liver disease. Zinc levels correlated with INR (r = −0.56, p < 0.001), bilirubin (r = −0.51, p < 0.001), and albumin (r = 0.68, p < 0.001), and were lower in patients with ascites (0.40 vs. 0.57 mcg/ml, p < 0.001), encephalopathy (0.40 vs. 0.53 mcg/ml, p < 0.001), diuretic use (0.45 vs. 0.535 mcg/ml, p = 0.005), and infection (0.32 vs. 0.51 mcg/ml, p < 0.001). Ascites (p = 0.044) and infection (p = 0.009) were independently associated with zinc levels. Zinc-deficient patients had lower transplant-free survival rates than non-deficient patients.

Conclusion

Zinc deficiency is highly prevalent in cirrhotic patients with Child–Pugh score B or C, and with MELD score ≥15. Zinc deficiency also correlates with disease severity, infection, and a worse transplant-free survival. Screening for zinc deficiency should be considered in this subset of patients.
Literatur
1.
Zurück zum Zitat Bartholomay AF, Robin ED, Vallee RL, Wacker WE. Zinc metabolism in hepatic dysfunction. I. Serum zinc concentrations in Laennec’s cirrhosis and their validation by sequential analysis. N Engl J Med. 1956;255:403–408.CrossRefPubMed Bartholomay AF, Robin ED, Vallee RL, Wacker WE. Zinc metabolism in hepatic dysfunction. I. Serum zinc concentrations in Laennec’s cirrhosis and their validation by sequential analysis. N Engl J Med. 1956;255:403–408.CrossRefPubMed
2.
Zurück zum Zitat Fredricks RE, Tanaka KR, Valentine WN. Zinc in human blood cells: normal values and abnormalities associated with liver disease. J Clin Investig. 1960;39:1651–1656.PubMedCentralCrossRefPubMed Fredricks RE, Tanaka KR, Valentine WN. Zinc in human blood cells: normal values and abnormalities associated with liver disease. J Clin Investig. 1960;39:1651–1656.PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Gil EB, Ruiz MM, Cantero HJ, Diez RA, Rodrigo MM. Zinc and liver cirrhosis. Acta Gastroenterol Belg. 1990;53:292. Gil EB, Ruiz MM, Cantero HJ, Diez RA, Rodrigo MM. Zinc and liver cirrhosis. Acta Gastroenterol Belg. 1990;53:292.
5.
Zurück zum Zitat Stamoulis I, Kouraklis G, Theocharis S. Zinc and the liver: an active interaction. Dig Dis Sci. 2007;52:1595–1612.CrossRefPubMed Stamoulis I, Kouraklis G, Theocharis S. Zinc and the liver: an active interaction. Dig Dis Sci. 2007;52:1595–1612.CrossRefPubMed
6.
Zurück zum Zitat Rocchi E, Borella P, Borghi A, et al. Zinc and magnesium in liver cirrhosis. Eur J Clin Invest. 1994;24:149–155.CrossRefPubMed Rocchi E, Borella P, Borghi A, et al. Zinc and magnesium in liver cirrhosis. Eur J Clin Invest. 1994;24:149–155.CrossRefPubMed
7.
Zurück zum Zitat Poo JL, Rosas-Romero R, Rodriguez F, et al. Serum zinc concentrations in two cohorts of 153 healthy subjects and 100 cirrhotic patients from Mexico City. Dig Dis. 1995;13:136–142.CrossRefPubMed Poo JL, Rosas-Romero R, Rodriguez F, et al. Serum zinc concentrations in two cohorts of 153 healthy subjects and 100 cirrhotic patients from Mexico City. Dig Dis. 1995;13:136–142.CrossRefPubMed
8.
Zurück zum Zitat Umusig-Quitain P, Gregorio GV. High incidence of zinc deficiency among Filipino children with compensated and decompensated liver disease. J Gastroenterol Hepatol. 2010;25:387–390.CrossRefPubMed Umusig-Quitain P, Gregorio GV. High incidence of zinc deficiency among Filipino children with compensated and decompensated liver disease. J Gastroenterol Hepatol. 2010;25:387–390.CrossRefPubMed
9.
Zurück zum Zitat Pescovitz MD, Mehta PL, Jindal RM, Milgrom ML, Leapman SB, Filo RS. Zinc deficiency and its repletion following liver transplantation in humans. Clin Transplant. 1996;10:256–260.PubMed Pescovitz MD, Mehta PL, Jindal RM, Milgrom ML, Leapman SB, Filo RS. Zinc deficiency and its repletion following liver transplantation in humans. Clin Transplant. 1996;10:256–260.PubMed
10.
Zurück zum Zitat Karayalcin S, Arcasoy A, Uzunalimoglu O. Zinc plasma levels after oral zinc tolerance test in nonalcoholic cirrhosis. Dig Dis Sci. 1988;33:1096–1102.CrossRefPubMed Karayalcin S, Arcasoy A, Uzunalimoglu O. Zinc plasma levels after oral zinc tolerance test in nonalcoholic cirrhosis. Dig Dis Sci. 1988;33:1096–1102.CrossRefPubMed
11.
Zurück zum Zitat Valberg LS, Flanagan PR, Ghent CN, Chamberlain MJ. Zinc absorption and leukocyte zinc in alcoholic and nonalcoholic cirrhosis. Dig Dis Sci. 1985;30:329–333.CrossRefPubMed Valberg LS, Flanagan PR, Ghent CN, Chamberlain MJ. Zinc absorption and leukocyte zinc in alcoholic and nonalcoholic cirrhosis. Dig Dis Sci. 1985;30:329–333.CrossRefPubMed
12.
Zurück zum Zitat Keeling PW, Ruse W, Bull J, Hannigan B, Thompson RP. Direct measurement of the hepatointestinal extraction of zinc in cirrhosis and hepatitis. Clin Sci. 1981;61:441–444.CrossRefPubMed Keeling PW, Ruse W, Bull J, Hannigan B, Thompson RP. Direct measurement of the hepatointestinal extraction of zinc in cirrhosis and hepatitis. Clin Sci. 1981;61:441–444.CrossRefPubMed
13.
Zurück zum Zitat Scholmerich J, Becher MS, Kottgen E, et al. The influence of portosystemic shunting on zinc and vitamin A metabolism in liver cirrhosis. Hepatogastroenterology. 1983;30:143–147.PubMed Scholmerich J, Becher MS, Kottgen E, et al. The influence of portosystemic shunting on zinc and vitamin A metabolism in liver cirrhosis. Hepatogastroenterology. 1983;30:143–147.PubMed
14.
Zurück zum Zitat Ijuin H. Evaluation of pancreatic exocrine function and zinc absorption in alcoholism. Kurume Med J. 1998;45:1–5.CrossRefPubMed Ijuin H. Evaluation of pancreatic exocrine function and zinc absorption in alcoholism. Kurume Med J. 1998;45:1–5.CrossRefPubMed
15.
Zurück zum Zitat Giroux EL, Durieux M, Schechter PJ. A study of zinc distribution in human serum. Bioinorg Chem. 1976;5:211–218.CrossRefPubMed Giroux EL, Durieux M, Schechter PJ. A study of zinc distribution in human serum. Bioinorg Chem. 1976;5:211–218.CrossRefPubMed
16.
Zurück zum Zitat Schechter PJ, Giroux EL, Schlienger JL, Hoenig V, Sjoerdsma A. Distribution of serum zinc between albumin and alpha2-macroglobulin in patients with decompensated hepatic cirrhosis. Eur J Clin Invest. 1976;6:147–150.CrossRefPubMed Schechter PJ, Giroux EL, Schlienger JL, Hoenig V, Sjoerdsma A. Distribution of serum zinc between albumin and alpha2-macroglobulin in patients with decompensated hepatic cirrhosis. Eur J Clin Invest. 1976;6:147–150.CrossRefPubMed
17.
Zurück zum Zitat Lindeman RD, Baxter DJ, Yunice AA, Kraikitpanitch S. Serum concentrations and urinary excretions of zinc in cirrhosis, nephrotic syndrome and renal insufficiency. Am J Med Sci. 1978;275:17–31.CrossRefPubMed Lindeman RD, Baxter DJ, Yunice AA, Kraikitpanitch S. Serum concentrations and urinary excretions of zinc in cirrhosis, nephrotic syndrome and renal insufficiency. Am J Med Sci. 1978;275:17–31.CrossRefPubMed
18.
Zurück zum Zitat Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology. 1996;23:1084–1092.CrossRefPubMed Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology. 1996;23:1084–1092.CrossRefPubMed
19.
Zurück zum Zitat Riggio O, Ariosto F, Merli M, et al. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Dig Dis Sci. 1991;36:1204–1208.CrossRefPubMed Riggio O, Ariosto F, Merli M, et al. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial. Dig Dis Sci. 1991;36:1204–1208.CrossRefPubMed
20.
Zurück zum Zitat Reding P, Duchateau J, Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial. Lancet. 1984;2:493–495.CrossRefPubMed Reding P, Duchateau J, Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial. Lancet. 1984;2:493–495.CrossRefPubMed
21.
Zurück zum Zitat Chavez-Tapia NC, Cesar-Arce A, Barrientos-Gutierrez T, Villegas-Lopez FA, Mendez-Sanchez N, Uribe M. A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy. Nutr J. 2013;12:74.PubMedCentralCrossRefPubMed Chavez-Tapia NC, Cesar-Arce A, Barrientos-Gutierrez T, Villegas-Lopez FA, Mendez-Sanchez N, Uribe M. A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy. Nutr J. 2013;12:74.PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Takuma Y, Nouso K, Makino Y, Hayashi M, Takahashi H. Clinical trial: oral zinc in hepatic encephalopathy. Aliment Pharmacol Ther. 2010;32:1080–1090.CrossRefPubMed Takuma Y, Nouso K, Makino Y, Hayashi M, Takahashi H. Clinical trial: oral zinc in hepatic encephalopathy. Aliment Pharmacol Ther. 2010;32:1080–1090.CrossRefPubMed
23.
Zurück zum Zitat Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 1998;68:447S–463S.PubMed Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 1998;68:447S–463S.PubMed
24.
Zurück zum Zitat Wong CP, Ho E. Zinc and its role in age-related inflammation and immune dysfunction. Mol Nutr Food Res. 2012;56:77–87.CrossRefPubMed Wong CP, Ho E. Zinc and its role in age-related inflammation and immune dysfunction. Mol Nutr Food Res. 2012;56:77–87.CrossRefPubMed
25.
Zurück zum Zitat Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr. 2004;24:277–298.CrossRefPubMed Fraker PJ, King LE. Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr. 2004;24:277–298.CrossRefPubMed
26.
Zurück zum Zitat Ibs KH, Rink L. Zinc-altered immune function. J Nutr. 2003;133:1452S–1456S.PubMed Ibs KH, Rink L. Zinc-altered immune function. J Nutr. 2003;133:1452S–1456S.PubMed
27.
Zurück zum Zitat Yoffe B, Pollack S, Ben-Porath E, Zinder O, Barzilai D, Gershon H. Natural killer cell activity in post-necrotic cirrhotic patients as related to hepatitis-B virus infection and plasma zinc levels. Immunol Lett. 1986;14:15–19.CrossRefPubMed Yoffe B, Pollack S, Ben-Porath E, Zinder O, Barzilai D, Gershon H. Natural killer cell activity in post-necrotic cirrhotic patients as related to hepatitis-B virus infection and plasma zinc levels. Immunol Lett. 1986;14:15–19.CrossRefPubMed
28.
Zurück zum Zitat Allen JI, Perri RT, McClain CJ, Kay NE. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. J Lab Clin Med. 1983;102:577–589.PubMed Allen JI, Perri RT, McClain CJ, Kay NE. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. J Lab Clin Med. 1983;102:577–589.PubMed
29.
Zurück zum Zitat Kabu K, Yamasaki S, Kamimura D, et al. Zinc is required for Fc epsilon RI-mediated mast cell activation. J Immunol. 2006;177:1296–1305.CrossRefPubMed Kabu K, Yamasaki S, Kamimura D, et al. Zinc is required for Fc epsilon RI-mediated mast cell activation. J Immunol. 2006;177:1296–1305.CrossRefPubMed
30.
Zurück zum Zitat Wirth JJ, Fraker PJ, Kierszenbaum F. Zinc requirement for macrophage function: effect of zinc deficiency on uptake and killing of a protozoan parasite. Immunology. 1989;68:114–119.PubMedCentralPubMed Wirth JJ, Fraker PJ, Kierszenbaum F. Zinc requirement for macrophage function: effect of zinc deficiency on uptake and killing of a protozoan parasite. Immunology. 1989;68:114–119.PubMedCentralPubMed
31.
Zurück zum Zitat Beck FW, Prasad AS, Kaplan J, Fitzgerald JT, Brewer GJ. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol. 1997;272:E1002–E1007.PubMed Beck FW, Prasad AS, Kaplan J, Fitzgerald JT, Brewer GJ. Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans. Am J Physiol. 1997;272:E1002–E1007.PubMed
32.
Zurück zum Zitat Dowd PS, Kelleher J, Guillou PJ. T-lymphocyte subsets and interleukin-2 production in zinc-deficient rats. Br J Nutr. 1986;55:59–69.CrossRefPubMed Dowd PS, Kelleher J, Guillou PJ. T-lymphocyte subsets and interleukin-2 production in zinc-deficient rats. Br J Nutr. 1986;55:59–69.CrossRefPubMed
33.
Zurück zum Zitat DePasquale-Jardieu P, Fraker PJ. Interference in the development of a secondary immune response in mice by zinc deprivation: persistence of effects. J Nutr. 1984;114:1762–1769.PubMed DePasquale-Jardieu P, Fraker PJ. Interference in the development of a secondary immune response in mice by zinc deprivation: persistence of effects. J Nutr. 1984;114:1762–1769.PubMed
Metadaten
Titel
Screening for Zinc Deficiency in Patients with Cirrhosis: When Should We Start?
verfasst von
Shreya Sengupta
Kristen Wroblewski
Andrew Aronsohn
Nancy Reau
K. Gautham Reddy
Donald Jensen
Helen Te
Publikationsdatum
01.10.2015
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 10/2015
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3613-0

Weitere Artikel der Ausgabe 10/2015

Digestive Diseases and Sciences 10/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.